These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27758776)

  • 1. The Effects of Acetazolamide on the Evaluation of Cerebral Hemodynamics and Functional Connectivity Using Blood Oxygen Level-Dependent MR Imaging in Patients with Chronic Steno-Occlusive Disease of the Anterior Circulation.
    Wu J; Dehkharghani S; Nahab F; Allen J; Qiu D
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):139-145. PubMed ID: 27758776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial Spin Labeling Perfusion Magnetic Resonance Image with Dual Postlabeling Delay: A Correlative Study with Acetazolamide Loading (123)I-Iodoamphetamine Single-Photon Emission Computed Tomography.
    Haga S; Morioka T; Shimogawa T; Akiyama T; Murao K; Kanazawa Y; Sayama T; Arakawa S
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):1-6. PubMed ID: 26387043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brain Thermal Response as a Potential Neuroimaging Biomarker of Cerebrovascular Impairment.
    Fleischer CC; Wu J; Qiu D; Park SE; Nahab F; Dehkharghani S
    AJNR Am J Neuroradiol; 2017 Nov; 38(11):2044-2051. PubMed ID: 28935624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility-weighted MR for evaluation of vasodilatory capacity with acetazolamide challenge.
    Ohnishi T; Nakano S; Yano T; Hoshi H; Jinnouchi S; Nagamachi S; Flores L; Watanabe K; Yokogami K; Ohta H
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):631-7. PubMed ID: 8730181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral hemodynamic impairment: assessment with resting-state functional MR imaging.
    Amemiya S; Kunimatsu A; Saito N; Ohtomo K
    Radiology; 2014 Feb; 270(2):548-55. PubMed ID: 24072777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim E; Sohn CH; Na DG; Kim JE; Chang KH; Kim JH; Jeon SJ
    J Comput Assist Tomogr; 2009; 33(4):546-51. PubMed ID: 19638847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetazolamide-augmented dynamic BOLD (aczBOLD) imaging for assessing cerebrovascular reactivity in chronic steno-occlusive disease of the anterior circulation: An initial experience.
    Wu J; Dehkharghani S; Nahab F; Qiu D
    Neuroimage Clin; 2017; 13():116-122. PubMed ID: 27942454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Blood Oxygenation Level-Dependent fMRI and Provocative DSC Perfusion MR Imaging for Monitoring Cerebrovascular Reserve in Intracranial Chronic Cerebrovascular Disease.
    Thulborn KR; Atkinson IC; Alexander A; Singal M; Amin-Hanjani S; Du X; Alaraj A; Charbel FT
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):448-453. PubMed ID: 29371256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide-Loaded Dynamic 7T MR Quantitative Susceptibility Mapping in Major Cerebral Artery Steno-Occlusive Disease: Comparison with PET.
    Fujimoto K; Uwano I; Sasaki M; Oshida S; Tsutsui S; Yanagihara W; Fujiwara S; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
    AJNR Am J Neuroradiol; 2020 May; 41(5):785-791. PubMed ID: 32299799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resting-state Functional Magnetic Resonance Imaging Identifies Cerebrovascular Reactivity Impairment in Patients With Arterial Occlusive Diseases: A Pilot Study.
    Nishida S; Aso T; Takaya S; Takahashi Y; Kikuchi T; Funaki T; Yoshida K; Okada T; Kunieda T; Togashi K; Fukuyama H; Miyamoto S
    Neurosurgery; 2019 Nov; 85(5):680-688. PubMed ID: 30247676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
    Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
    Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Masuda K
    Stroke; 1995 Oct; 26(10):1825-9. PubMed ID: 7570733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases.
    Saito H; Ogasawara K; Suzuki T; Kuroda H; Kobayashi M; Yoshida K; Kubo Y; Ogawa A
    Neurol Med Chir (Tokyo); 2011; 51(7):479-83. PubMed ID: 21785240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral MR oximetry during acetazolamide augmentation: Beyond cerebrovascular reactivity in hemodynamic failure.
    Leatherday C; Dehkharghani S; Nahab F; Allen JW; Wu J; Hu R; Qiu D
    J Magn Reson Imaging; 2019 Jul; 50(1):175-182. PubMed ID: 30390367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.
    Siero JC; Hartkamp NS; Donahue MJ; Harteveld AA; Compter A; Petersen ET; Hendrikse J
    Neuroimage; 2015 Jan; 105():276-85. PubMed ID: 25261002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tissue heterogeneity on cerebral vascular response to acetazolamide stress measured by an I-123-IMP autoradiographic method with single-photon emission computed tomography.
    Ito H; Shidahara M; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Kaneta T; Sato K; Sato T; Fukuda H
    Ann Nucl Med; 2005 Jun; 19(4):251-60. PubMed ID: 16097633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Hemodynamic Compromise Using Computed Tomography Perfusion in Combination with
    Hashimoto A; Mikami T; Komatsu K; Noshiro S; Hirano T; Wanibuchi M; Mikuni N
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):627-635. PubMed ID: 27939758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT measurements of cerebral blood volume before and after acetazolamide in occlusive cerebrovascular diseases.
    Inoue Y; Momose T; Machida K; Honda N; Nishikawa J; Sasaki Y
    Radiat Med; 1994; 12(5):225-9. PubMed ID: 7863027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with (133)Xe SPECT in occlusive cerebrovascular disease.
    Kikuchi K; Murase K; Miki H; Yasuhara Y; Sugawara Y; Mochizuki T; Ikezoe J; Ohue S
    AJR Am J Roentgenol; 2002 Jul; 179(1):229-35. PubMed ID: 12076942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of misery perfusion with split-dose 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases.
    Imaizumi M; Kitagawa K; Hashikawa K; Oku N; Teratani T; Takasawa M; Yoshikawa T; Rishu P; Ohtsuki T; Hori M; Matsumoto M; Nishimura T
    Stroke; 2002 Sep; 33(9):2217-23. PubMed ID: 12215590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.